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Transcription factorThe homeobox-containing gene Arx is expressed during ventral telencephalon development and required for
correct GABAergic interneuron tangential migration from the ganglionic eminences to the olfactory bulbs,
cerebral cortex and striatum. Its human ortholog is associated with a variety of neurological clinical
manifestations whose symptoms are compatible with the loss of cortical interneurons and altered basal
ganglia-related activities. Herein, we report the identiﬁcation of a number of genes whose expression is
consistently altered in Arx mutant ganglionic eminences. Our analyses revealed a striking ectopic expression
in the ganglionic eminences of several of these genes normally at most marginally expressed in the ventral
telencephalon. Among them, Ebf3 was functionally analyzed. Thus, its ectopic expression in ventral
telencephalon was found to prevent neuronal tangential migration. Further, we showed that Arx is sufﬁcient
to repress Ebf3 endogenous expression and that its silencing in Arx mutant tissues partially rescues
tangential cell movement. Together, these data provide new insights into the molecular pathways regulated
by Arx during telencephalon development.
© 2009 Elsevier Inc. All rights reserved.Introduction
In the last decade, outstanding progress has been made in our
actual understanding of the molecular mechanisms involved in the
patterning of the telencephalon. Hence, complex interactions
between a number of extrinsic and intrinsic cellular factors were
implicated in the subdivision of the telencephalon into different
territories exhibiting distinct cellular features (Wilson and Ruben-
stein, 2000; Guillemot, 2005; Rash and Grove, 2006; Hébert and
Fishell, 2008). For instance, signaling molecules belonging to the FGF,
Wnt, Shh and RA families, secreted from distinct signaling centers,
act to establish positional information along the anterior neuraxis
and thereby create a primitive protomap of the telencephalic
primordium (Shimamura and Rubenstein, 1997; Fuccillo et al.,logy Laboratory, San Raffaele
Fax: +39 2 26434621.
l rights reserved.2004; Marklund et al., 2004; Shimogori et al., 2004). These nascent
territories express speciﬁc sets of transcription factors acting to
deﬁne deﬁnitive anatomical and cellular organizations. Recent
studies have revealed how successive cascades of such nuclear
factors may regulate these processes: early neuronal commitment is
induced by bHLH proneural factors which, in turn, interact with
homeoproteins or other nuclear proteins to deﬁne the cell fate and
organization of each territory (Castro et al., 2006; Gohlke et al.,
2008). In particular, in the ventral telencephalon, the Mash1
proneural factor directly promotes the transcription of the Dlx1 and
2 homeobox genes, which in turn, support GABAergic subtype
neuronal differentiation and tangential migration (Cobos et al.,
2005a,b; Cobos et al., 2007; Poitras et al., 2007). Concomitantly,
Dlx1 and 2 proteins activate the Dlx5, Dlx6 and Arx transcription
factors (Zerucha et al., 2000; Colasante et al., 2008). Dlx5 and 6 were
found to play a major role in controlling olfactory bulb interneuron
commitment and migration (Levi et al., 2003; Long et al., 2003).
Conversely, Arx displays multiple functions in ventral telencephalon
morphogenesis, in radial and tangential migrations of GABAergic
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neurons (Kitamura et al., 2002; Colombo et al., 2007; Friocourt et
al., 2008). Notably, mutations in the human ARX ortholog were
associated with a wide range of neurological disorders. For instance,
missense mutations or expansion of polyalanine tracts were linked to
an important number of neuropathological diseases, including
idiopathic mental retardation, epilepsy, early infantile epileptic
encephalopathy and diskinetic quadriparesis, as well as more
complex syndromic conditions, such as West, Proud and Partington
syndromes (Strømme et al., 2002; Bienvenu et al., 2002; Kato and
Dobyns, 2005; Kato et al., 2005, 2007; Gécz et al., 2006; Guerrini et
al., 2007). More severe mutations within the ARX gene resulting in
premature termination of the protein, have been reported in X-linked
lissencephaly with abnormal genitalia (XLAG) patients (Kitamura et
al., 2002; Kato and Dobyns, 2003, 2005). The latter exhibit severe
brain malformations, including agenesis of corpus callosum, reduced
and fragmented basal ganglia, and severe reduction in cortical
GABAergic interneuron numbers associated with their aberrant
distribution in the white matter and neocortical subventricular
zone (Kitamura et al., 2002; Gécz et al., 2006; Colombo et al.,
2007; Okazaki et al., 2008). Interestingly, such phenotypic mal-
formations are also detectable in neonatal Arx mutant mice, although
their perinatal death, due to pancreatic complications, has prevented
a consistent behavioral analysis (Kitamura et al., 2002; Colombo et
al., 2007; Collombat et al., 2003).
Despite its dramatic impact on brain morphogenesis, very little is
known concerning the mechanisms underlying Arx pleiotropic
activities, as well as its downstream targets. Few research groups
have recently initiated a systematic identiﬁcation of the molecular
effectors of key transcription factors acting throughout brain
development (Castro et al., 2006; Gohlke et al., 2008). Such pioneer
studies have allowed us to gain further insight into the transcrip-
tional machinery controlling brain neurogenesis. Herein, aiming to
uncover at least some of the Arx downstream targets, we performed
a gene expression proﬁle analysis comparing wild-type (wt) and
Arx mutant ventral telencephalic tissues. Strikingly, a fairly small
number of genes were found consistently misregulated in the
mutant tissues as compared to controls. Speciﬁcally, Ebf3 was
identiﬁed as a putative Arx target gene, its expression being more
than six-time increased in Arx-deﬁcient animals. Subsequent
functional analyses indicated that such up-regulation in the basal
ganglia was detrimental for tangential migration of GABAergic
neuronal progenitors. Further, knock-down experiments targeting
Ebf3 in Arx mutant tissues were found to only partially rescue
neuronal migration defects following radial routes towards striatal
and pallidal mantle zones, but also migration pathways leading to
the cortical plate.Materials and methods
Animals
Arx mutant mice (Collombat et al., 2003) were maintained by
backcrossing with C57Bl/6 animals. Timed-pregnant mice were
considered embryonic day 0.5 (E0.5) on the morning of the conﬁrma-
tion of the vaginal plug. Genotyping was performed by morphological
assessment and conﬁrmed by PCR using a mixture of three primers to
identify thewild-type (wt) and themutant alleles, generating 0.25 and
0.4 kb PCR products, respectively (primer 1, 5′-CGGCTCACTACACTTGT-
TACCGCTTGGTCC-3′; primer 2, 5′-AGCAGCCCTCTTCCTGGTACTGATT-
GCTC-3′; and primer 3, 5′-TGCTGCAAGGCGATAAGTTGGGTAACGC-3′)
(Collombat et al., 2003). Mice were maintained at the San Raffaele
Scientiﬁc Institute Institutional mouse facility, and experiments were
performed in accordance with experimental protocols approved by
local Institutional Animal Care and Use Committees (IACUC).RNA isolation, processing, and microarray analysis
Three timed-pregnant Arx heterozygous dams crossedwith C57Bl/
6 males were sacriﬁced at E14.5, their embryos were harvested and
placed into cold PBS. Following brain isolation, meninges and olfactory
bulbs were removed, and the ventral telencephalon was separated
from the overlying cerebral cortex. The same procedure was repeated
for 5 wt and 5 Arx mutant embryos. Total RNAwas extracted from the
tissues using the Qiagen RNA micro kit (Qiagen, Valencia, CA). cRNAs
were generated and hybridized on a total of ten different MOE430v2
Affymetrix DNA chips according to the Affymetrix protocol. The chips
were scanned with a speciﬁc scanner (Affymetrix) to generate
digitized image data ﬁles. The data were deposited in the NCBI Gene
Expression Omnibus (Edgar R, Domrachev M, Lash AE. Gene
Expression Omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 2002; 30:207–10) and are
accessible through GEO Series.
Microarray data analysis
Microarray quality control and statistical validation were per-
formed using Bioconductor (Gentleman et al., 2004; Sanges et al.,
2007). Background correction, normalization, and probe set inten-
sities were obtained bymeans of GCRMA (Wu and Irizarry, 2004). The
number of genes evaluated was reduced by applying an interquartile
(IQR) ﬁlter followed by an intensity ﬁlter to remove the not signiﬁcant
probe sets, i.e. not expressed and those not changing (Huber et al.,
2002; Cordero et al., 2007). Principal component analysis (PCA)
(Raychaudhuri et al., 2000) was used to investigate the overall
behavior of the two experimental conditions.
To assess differential expression, we used an empirical Bayes
method (Smyth, 2004) together with a false discovery rate (FDR)
correction of the P-value (Westfall and Young, 1993). Thus, the list of
differentially expressed genes was generated using an FDR ≤0.05
together with an absolute log2(fold-change) threshold of 1 and by
selecting those probe sets mapping to unique Entrez Gene identiﬁers
(Maglott et al., 2005).
Functional annotation was performed using Ingenuity knowledge
base (www.ingenuity.com), which enables the analysis, and the
understanding of the complex biological and chemical systems taking
advantage of a manually curate knowledge base.
Hierarchical clustering and PCA analysis were performed using
TMEV software (www.tigr.org). Array data were deposited on GEO
data base (# GSE12956).
Quantitative real-time PCR and quantiﬁcation
2 μg of the total RNA extracted from wt and Arx mutant ventral
telencephali were reverse transcribed with random hexamers as
primers using a Thermoscript RetroTranscriptase (Invitrogen). The
oligonucleotides used for the ampliﬁcation of selected genes are
reported in Table S2. qRT-PCRs were carried out in a ﬁnal volume of
25 μl, containing a concentration of 100 nM of each primer, 1× Syber
Green mix (Biorad) and 2 μl of the RT products. Thermal cycling was
performed using aMx3005P QPCR system (Stratagene). Melting curve
analysis was performed for each reaction to ensure a single peak and
amplicons were visualized after electrophoresis on a 2% agarose gel to
ensure the presence of a single PCR product.
The Livak method was applied for quantiﬁcation (Schmittgen and
Livak, 2008). Brieﬂy, the expression of each gene either in wild-type
or in mutant samples was normalized to that of the housekeeping
gene β-actin: to this purpose a ΔCT, WT=(CT, gene−CT, act)WT and a
ΔCT, MUT=(CT, gene−CT, act)MUT were calculated for each ampliﬁed
gene and results were reported as fold change (2−ΔΔCT) in gene
expression of Arx mutant samples relative to the wild-type, where
−ΔΔCT=−(ΔCT, MUT−ΔCT, WT).
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ISHs on frozen sections were performed as previously described
by Schaeren-Wiemers and Gerﬁn-Moser (1993) with the modiﬁca-
tions previously reported in Colombo et al. (2007). Whole mount
ISHs were carried out as previously described (Broccoli et al., 2002).
Fluorescent ISHs were performed following regular protocols until
incubation with anti-DIG primary antibody. After washing, the
tetramethylrhodamine tyramide ampliﬁcation reagent (TSA™ Plus
Fluorescent System Kit — NEN Life Science Products) was applied on
each slide and incubated for 10 min. The slides were washed and
processed for anti-GFP immunohistochemistry (GFP polyclonal anti-
body, Molecular Probes). The following probes were used: Bmper
(NM_028472, nt_2062–3313), Cxcr4 (a gift from Dr. Richard Miller),
Ebf3, Magel2 (XM_622091, nt_2281–3428), Lhx7/8 (generously
provided by Dr. Vassilis Pachnis), Lmo1 (NM_057173, nt_94–1124),
Lmo3 (NM_207222, nt_574–1882), Lmo4 (NM_010723, nt_354–
1296), Rasgef1b (NM_145839, nt_1308–2611), Zic5 (NM_022987,
nt_984–2115).Organotypic culture and focal electroporations
Slice cultures of E14.5 embryonic mouse forebrain or mesence-
phalon were prepared as previously described (Anderson et al.,
1997). Brieﬂy, mouse brains were isolated, embedded in 4% low-
melting agarose (Sigma) and 250 μm thick coronal sections were cut
on a vibratome (VT1100, Leica). The sections were then transferred
to polycarbonate membranes (diameter, 13 mm; pore size 8 μm;
Costar) in organ tissue dishes containing 1.5 ml of serum-containing
medium (Gibco a-MEM with 10%fetal calf serum, glutamine,
penicillin and streptomycin). Slices were maintained for 1 h at
37 °C in 5% CO2 in a standard sterile incubator. Before changing
to the Neurobasal/B27 (Gibco) medium, 1 μl of DNA plasmid
corresponding to 5 μg mixed with 0.03% fast-green dye in PBS
was mouth-injected in the area of interest of the brain slice and
the same area was electroporated with a square-electroporator
(ECM830, BTX, Holliston, MA) using planar electrodes (BTX) and
applying 2 electric pulses of 100 V for 5 ms as described by Stühmer
et al. (2002). The slices were examined for GFP expression under an
epiﬂuorescent dissecting microscope and photographed.
Mesencephalic slices, the day after electroporation, were ﬁxed in
4% PFA in PBS, cryoprotected in 30% sucrose, embedded in OCT
compound, and sectioned on a cryostat (10 μm) for ISHs and
immunohistochemistry.
For in vivo validation of Ebf3 shRNA and conﬁrmation of Ebf3
repression by Arx, 48 h after electroporation, the targeted tissues were
dissected and processed for RNA extraction.DNA and shRNA plasmids
Full-coding sequences for Ebf3, Lmo3 and Arx were cloned in the
pCAG expression vector (Niwa et al., 1991) upstream to an IRES-GFP
cassette. The shRNA used for the Ebf3 silencing is Clone ID
NM_010096.1-712s1c1 (Sigma-Aldrich), which is cloned in pLKO.1-
puro plasmid. Its sequence is: CCGGCGTTGTATCGACAACAGTCAACTC-
GAGTTGACTGTTGTCGATACAACGTTTTTG. A Non-Target shRNA Control
Vector (SHC002, Sigma), containing a sequence that does not target
any mouse genes cloned in the same plasmid pLKO.1-puro plasmid,
was used as a negative control.
Ebf3⁎IRES-GFP construct, for the shRNA rescue experiments,
was obtained by site direct mutagenesis using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene) and the primers 5′-C
CAG GTC GTT GTT TCC ACG ACT GTC AAC GTG GAC-3′ and its reverse
complementary (mutagenized nucleotides are underlined).ShRNAs validation
Non-Target shRNA Control Vector (SHC002, Sigma) and ﬁve
different Ebf3 shRNA clones were tested (NM_010096.1–712s1c1,
NM_010096.1–461s1c1, NM_010096.1–460s1c1, NM_010096.1–
1085s1c1, NM_010096.1–2248s1c1 (Sigma-Aldrich)) in Ebf3 silencing
assay. For testing the silencing efﬁciency of these Ebf3 shRNA
constructs, each plasmid was mixed with a pCAGGs-GFP plasmid
(3:1 ratio) and 293T cells were transfected by Lipofectamine Reagent
(Invitrogen) with Ebf3-GFP fused construct alone and in association
with each Ebf3 shRNA clone or control shRNA plasmids (1:1 ratio).
48 h after transfection, pictures from each transfection set-up were
taken and silencing efﬁciency was evaluated by monitoring GFP
expression. The clone NM_010096.1-712s1c1 was selected and GFP
reduction was quantiﬁed by Western blot analysis with an antibody
against the GFP protein.
For in vivo validation of Ebf3 shRNA, the previously selected
construct (NM_010096.1-712s1c1) and the control shRNAweremixed
with pCAG-GFP (1:1) and focally injected and electroporated in
organotypic slice of dorsal midbrain; 48 h after electroporation, GFP+
areas were dissected and processed for RNA extraction; cDNA was
generated and quantitative RT-PCR for Ebf3, GFP, and β-actin were
performed.
After determining the 2−ΔΔCTEbf3 and 2−ΔΔCTGFP, comparing
Ebf3 shRNA electroporated tissues to control shRNA electroporated
ones (as previously shown), the relative Ebf3 expression level
was normalized on the electroporation efﬁciency by the product
of 2−ΔΔCTEbf3×2−ΔΔCTGFP.
Results
Identiﬁcation of genes differentially expressed in the Arx mutant versus
wild-type ventral telencephalon by transcriptome analysis
To gain insight into the Arx-dependent transcriptional gene
network, we sought to assess changes in global gene expression in
Arx mutant ventral telencephalon. The selection of the proper
developmental stage was of importance as different cellular
processes, such as cell proliferation, neuronal commitment and
cellular migration, although partially overlapping, exhibit their own
speciﬁc dynamics and peaks during embryogenesis. Therefore, we
chose to focus our analysis at embryonic stage 14.5, when a robust
tangential migration of GABAergic progenitors originating from the
basal ganglia occurs. Embryonic brains were harvested and the
ventral telencephalon including medial, lateral and caudal ganglionic
eminences, as well as anterior ectopeduncular (AEP) and preoptic
area (POA), was carefully dissected and processed for gene expres-
sion proﬁling (Fig. 1A). RNA was extracted from the isolated tissue
and used to hybridize Affymetrix microarrays (MOE430v2) contain-
ing 45,101 probe sets. Neural tissues from Arx mutant (n=5) and wt
(n=5) embryos were independently processed on 10 different gene-
chips in order to minimize individual biological differences. 14,775
set probes were selected following IQR ﬁltering (N0.25) and 7356
remained after applying a threshold on ﬁlter intensity (intensity
N100 in more than 50% of the experimental data). Data sets were
then used to identify differentially expressed transcripts. Using a log2
(fold-change ≥1 and a FDR ≤0.05) linear model analysis revealed
that 46 probe sets, corresponding to 38 different Entrez Gene
Identiﬁers, were misregulated comparing Arx mutant and wt tissues
(Table S1). Among them, 3 genes (DDX3Y, EIF2S3Y and CMCY) were
considered as Arx-independently misregulated. In fact, they corre-
spond to Y-linked expressing units and their up-regulation in mutant
tissues is indicative of a sex-biased harvest of the embryos. This was
expected as Arx mutants were all males (ArxY/−), while wild-type
embryos displayed an equal probability to be males or females. The
remaining 35 genes were clustered upon the biological function of
Fig. 1. Outline of the gene expression proﬁle analysis and hierarchical clustering of the 35 transcripts found differentially expressed between wt and Arx mutant ventral
telencephalon. (A) Lateral and medial ganglionic eminences (LGE, MGE) and anterior ectopeduncular area (AEP) were dissected from the telencephalon leaving out the cerebral
cortex from ﬁve different E14.5 Arx mutant and wild-type brains. RNA was extracted from the isolated tissues, cRNA was generated and hybridized on a total of ten MOE430v2
Affymetrix DNA chips. (B–G) 2D hierarchical clustering of the 35 transcripts found differentially expressed between wt and Arx mutant brains. Clustering was performed using
Euclidean distance metric and average linkage after data were mean centered at gene level. The 35 genes are grouped based of their protein function: (B) extra-cellular regulatory
proteins; (C) intracellular regulatory proteins; (D) structural proteins; (E) transcription factors and nuclear proteins; (F) receptors and trans-membrane proteins; (G)
uncharacterized coding units.
62 G. Colasante et al. / Developmental Biology 334 (2009) 59–71their gene products based on literature searches and Gene Ontology
(Figs. 1B–G). Interestingly, the largest group including a third of all
identiﬁed coding units (11/34), consisted of transcription factors
and DNA binding proteins (Fig. 1E). Moreover, the majority of the
misregulated genes were up-regulated (65%; 22/35); such resultwas in agreement with previous reports describing Arx as a
transcriptional repressor both in vitro and in brain tissue (McKenzie
et al., 2007; Colombo et al., 2007). However, 13 out of 35 (35%) of the
putative Arx target genes were found repressed in the Arx mutant
tissue, suggesting that they either represented not direct targets or
63G. Colasante et al. / Developmental Biology 334 (2009) 59–71that Arx might also act as a transcriptional activator in some
circumstances.
Validation of Arx putative target genes by quantitative real-time RT-PCR
and in situ hybridization
To ensure the reliability of our analysis, we selected 10 genes found
to be misregulated by microarray technology and analyzed their
expression in control and mutant tissues using quantitative real-time
RT-PCRs (qPCRs). Relative changes in gene expressionwere calculated
by the 2−ΔΔCT method (Schmittgen and Livak, 2008). The data
presented in Fig. 2 are displayed as fold changes in gene expression,
normalized to an endogenous housekeeping gene (β-actin), between
Arx mutant and wt ventral telencephali. In all cases analyzed, qPCR
results conﬁrmed previous gene-array analyses both for up-regulated
(Ebf3, Lmo1, Lmo3, Lmo4 and Map1b) genes, as well as repressed
(Cxcx4, Cxcr7, Rspo3, cMaf and Atp7a) ones (Fig. 2). However, the
magnitude of the changes in expression levels detected by qPCRs was,
in some cases, signiﬁcantly higher (up to 3 fold) as compared to
microarray analyses (Ebf3, Lmo1, Lmo3), while, in other instances, the
results were found comparable (Cxcr4, Cxcr7, Rspo3).
To further validate our data, in situ hybridization experiments were
performed in the developing forebrain at the same stage as the one
used for microarray gene proﬁling (E14.5), but also during late
embryogenesis (E18.5). Notably, for all the genes analyzed, we noticed
dramatic alterations in their expression proﬁle in the ventral
telencephalon (Arx expression domain), whereas a mostly normal
expression pattern was observed in other regions of the brain, such as
the cortex or the hypothalamus. Two classes of genes were outlined by
our analysis, depending on the alterations in gene expression detected
in Arx mutant tissues. Class I includes those genes normally never
transcribed in the ventral telencephalon, or only marginally, which
were found strongly and/or ectopically expressed in the Arx mutant
subpallium. Ebf3 was a remarkable example of Class I genes: it was
normally marginally detected in the developing telencephalon,
whereas, in the Arx mutants, it was found strongly misexpressed in
medial ganglionic eminence (MGE) and present in lateral ganglionic
eminence (LGE) (Figs. 3A–B′). Even at late stages of embryogenesis,
Ebf3 ectopic expression persisted in Arx mutant telencephalon,
where it could be detected into the differentiated striatal and pallidal
regions (Figs. 3C, C′). Interestingly, few Ebf3+ cells were also noticed
in the mutant, but not wt, cerebral cortex (Figs. 3D, D′, arrows). Their
distribution within the cerebral cortex coinciding with the white
matter and sub-ventricular zone was consistent with the ectopicFig. 2.Microarray data validation by quantitative RT-PCR for selected genes. The Cxcr4, Cxcr7
validation of their gene expression by quantitative real-time RT-PCR (qPCR). The expression o
gene β-actin and the results are reported as fold change in gene expression in Arx mutant
Quantitative real-time PCR conﬁrmed microarray data comparing Arx mutant samples with
control; dark gray bar: Arx mutant. Error bars correspond to S.D.location of Arx-deﬁcient GABAergic interneurons (Kitamura et al.,
2002; Colombo et al., 2007). Therefore, Arx mutant GABAergic
neurons likely maintained Ebf3 expression even after their exit from
the basal ganglia and during their migrationwithin the cortical tissue.
Similarly to Ebf3, Magel2, an imprinted gene associated with Prader–
Willi syndrome, was found ectopically expressed within the ventral
telencephalon, while its expression is normally restricted to the
hypothalamic and preoptic areas (Figs. 3E–F′) (Lee et al., 2003; Bischof
et al., 2007). Rasgef1b, a gene coding for an uncharacterized member
of the guanine nucleotide exchange factor family regulating Ras
activity, also appeared misexpressed in the SVZ basal ganglia, while
normally is located in the differentiated striatal mantle (Figs. 3G–H′).
To such Class I cluster also belonged members of the LMO gene
family (Lmo1, Lmo3, Lmo4). In particular, at E14.5, Lmo3 transcripts
were found strongly expressed in the mutant MGE territory, but also
in the mutant LGE ﬁeld (Figs. 3I–J′). At E18.5, Lmo3 remained
ectopically produced in MGE-derived territories and in SVZ regions of
the CGE (Figs. 3K–L′). Similarly, Lmo1 expression normally barely
detectable in the subpallial VZ and SVZ inwt, was up-regulated in SVZ
and in the MGE mantle zone of Arx mutant ventral telencephalon
(Figs. 3M–N′). Lastly, Lmo4 transcripts were observed only in the
mutant MGE (Figs. 3O–P′). Thus, all three Lmo genes were mis-
expressed in themutant SVZ andmantle area, two domains where Arx
is normally stronglyexpressed. In contrast, they lacked in theVZwhere
Arx is usually veryweakly produced (Colombo et al., 2004; Cobos et al.,
2005a,b). Such data support the notion that Arx acts to inhibit Lmo
genes and that its deﬁciency is sufﬁcient to induce their expression.
Genes down-regulated in the ventral telencephalon upon Arx gene
inactivation were grouped in Class II. Lhx7/8 and Zic5 (also known as
Opr, Furushima et al., 2000, 2005) genes, encoding for transcription
factors, were thereby uncovered. Lhx7/8 expression is normally
conﬁned to forebrain cholinergic neuronal progenitors where it was
found to be required for cholinergic differentiation and maturation
(Zhao et al., 2003; Fragkouli et al., 2005). Loss of cholinergic forebrain
neurons was previously reported in Arx mutants, as well as the loss of
early markers of cholinergic neuronal commitment (Colombo et al.,
2007). Accordingly, in Arx mutants, Lhx7/8 expression was drama-
tically reduced in basal telencephalic regions (Figs. 3Q, Q′). Zic5/Opr-
labelled cell number was also diminished in telencephalic septal areas
(Figs. 3R, R′). Although, Zic5/Opr function has hitherto not been
implicated in cholinergic neuronal differentiation, its restricted
expression in the septum, an important domain of cholinergic
neuronal differentiation, suggests a possible role in this biological
context. Bmper is an additional gene repressed in the Arx mutant, Ebf3, Lmo1, Lmo3, Lmo4, Rspo3,Map1b, cMaf, and Atp7a genes were further selected for
f each gene both inwt and mutant samples was normalized to that of the housekeeping
samples relative to wild-type, according to the Livak (2−ΔΔCT) quantiﬁcation method.
wild-type ones. Each set of PCR reactions was performed three times. Light gray bar:
Fig. 3. Analysis of Arx-regulated genes in the developing telencephalon by in situ hybridization. In situ hybridization on coronal sections of E14.5 telencephalon of a number of Arx
downstream candidate genes isolated by gene expression proﬁling. Wt and mutant brain tissues are directly compared for expression of each single gene with two side-by-side
photographs (wt on the left and Arxmutant on the right). (A–B′) Ebf3 transcripts are not detected inwt forebrain (A, B), while they are stronglymisexpressed in the Arxmutant MGE
(A′, B′). (C–D′) Ebf3 is ectopically detected in the striatum (Str), globus pallidus (GP) and in scattered cells of the cortical plate located within the white matter, such observations
probably indicative of aberrant migration of GABAergic interneurons (C′, D′, arrows). (E–F′) Magel2 expression is normally limited to the preoptic area (POA) in wild-type tissues
(E, F) whereas it is expanded to the whole ventral forebrain in Arx mutants (E′, F′). (G–H′) Rasgef1b expression is extended to the SVZ regions within the mutant ventral
telencephalon (G′, H′), while normally restricted to the differentiated striatal mantle zone (G, H). (I–L′) In E14.5 wild-type brains, Lmo3 transcripts are detected in archicortex and
pallidal mantle zones (I, J), whereas in Arx mutant telencephalon, they are found in MGE and LGE territories (I′, J′). (K–L′) At E18.5, Lmo3 ectopic expression remains detectable in all
MGE-derived territories (K′) and in the SVZ regions of the CGE (L′). (M–N′) Lmo1 expression is classically restricted to VZ/SVZ regions in wild-type tissues (M, N). However, in Arx
mutant brains, its expression reaches into the differentiating MGE domains (M′–N′). (O–P′) Lmo4 expression domain is enlarged in Arx mutant brains covering all MGE territories
(O′, P′), while normally restricted to the LGE (O–P). (Q–T′) Loss or reduction in gene expression in the Arx mutant tissues for Lhx7/8 (Q′), Zic5 (R′), Bmper (S′) and Cxcr4 (T′) as
compared to wt condition (Q, R, S, T). Cx, cortex; DG, dentate gyrus; GP, globus pallidus; Hy, hypothalamus; MGE, medial ganglionic eminence; LGE, lateral ganglionic eminence;
Se, septum; Str, striatum.
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telencephalon and cerebral cortex (Figs. 3S, S′) (Cofﬁnier et al., 2002).
This gene plays a key role in BMP signaling and has been implicated in
the induction of the forebrain cholinergic neuronal fate (Ambrosio et
al., 2008; Lopez-Coviella et al., 2005). Together, these ﬁndings suggest
that genes speciﬁc for the cholinergic differentiation program are
drastically repressed in Arx mutants and thereby conﬁrm the pivotal
role of Arx in initiating and/or promoting cholinergic differentiation
in the forebrain.
The last gene assayed by in situ hybridization was Cxcr4. Yet again,
a pronounced decrease in its expression was outlined in the Arx
mutant ventral telencephalon (Figs. 3T, T′). Cxcr4 encodes a receptor
speciﬁc for the SDF1/Cxcl12 chemokine, a chemotactic factor required
for the correct migration of forebrain GABAergic progenitors andCajal–Retzius cells (Stumm et al., 2003, 2007; Tiveron et al., 2006;
Borrell and Marín, 2006; López-Bendito et al., 2008). This result may
provide a putative link between the migration alterations observed in
Arx-deﬁcient mice and signaling pathways responsible for GABAergic
neuronal migration (see Discussion). In summary, our in situ gene
expression analysis ascertained our previous microarray and qPCR
ﬁndings and outlined alterations, some of which dramatic, in the
spatial expression pattern of our putative Arx target genes.
Ebf3 and Lmo3 are expressed in complementary neural domains during
development
To gain further insight into Arx function and its downstream
targets and determine their involvement in the alterations observed in
Fig. 4. Ebf3/Lmo3 and Arx genes exhibit non-overlapping, but closely adjacent,
expression domains during forebrain development. (A–B′) E10.5 wt embryos subjected
to whole mount RNA in situ hybridization to assess Ebf3 and Arx expression. Ebf3
expression is found in hindbrain (hb), midbrain (Mb) and the mammillary regions
(MM) of the hypothalamus at this early stage of development. Conversely, Arx
expression is detected in the telencephalon and ventral thalamus (VT). Thus, Ebf3 and
Arx expression domains never overlap, although they are found complementary in the
thalamic regions. (C, D) In situ hybridization on coronal sections of thalamic regions at
E14.5 demonstrates Ebf3 expression in speciﬁc hypothalamic nuclei (C), whereas Arx
expression is conﬁned to the ventral thalamic primordium (D). These two expression
domains remain completely separated, although closely adjacent (C, D, dashed lines).
(E, F) Similarly, Arx and Lmo3 are expressed in neighboring, but non-overlapping,
regions in the ventral forebrain. In fact, on E14.5 middle-position coronal sections, a
strong Arx expression is detected in the LGE, MGE and preoptic area (POA) (F), while
Lmo3 transcripts are restricted to the GP differentiated ﬁeld (E, dashed lines). CGE,
caudal ganglionic eminence; Cx, Cortex; DT, dorsal telencephalon; e, eye anlagen; ET,
eminentia thalami; Hb, hindbrain; Hy, hypothalamus; LGE, lateral ganglionic eminence;
Mb, midbrain; MGE, medial ganglionic eminence; MM, hypothalamic mammillary
bodies; VT, ventral telencephalon.
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focused on Ebf3 and Lmo3 as both of them displayed the greatest
increase in expression level upon Arx deﬁciency, such up-regulations
correlating with the transcriptional repression activity postulated for
Arx. Additionally, both genes encode transcription factors character-
ized by pleiotropic roles in neural development and neuronal
differentiation, suggesting that their misregulation may have a deep
impact on basal ganglia neurogenesis. In particular, Ebf3, a member of
the bHLH containing Ebf/Olf1 family, was found to control neurogen-
esis in the developing hindbrain and spinal cord (Pozzoli et al., 2003;
Garcia-Dominguez et al., 2002; Garel et al., 1997). Lmo3 encodes a
LIM-containing transcription factor highly related to Lmo1 and Lmo4,
all of which were strongly activated in Arx mutant tissue. LMO
proteins are expressed in several neural domains and required for the
correct development of the neural axis, their inactivation leading to
neonatal death (Tse et al., 2004; Bulchand et al., 2003). Interestingly,
we found that both Ebf3 and Lmo3 displayed expression patterns
complementary to that of Arx in the developing forebrain. In
particular, as early as E10.5, Ebf3 is strongly expressed in hindbrain,
midbrain and more rostrally in the hypothalamic mammillary regions
(Figs. 4A, A′). This last neural domain is located directly adjacent to the
Arx-expressing ventral diencephalon, but without any notable over-
lapping (Figs. 4B–B′). During subsequent brain development, Arx
expression in the diencephalon was found conﬁned to the ventral
thalamus, while Ebf3 transcripts were detected in the neighboring
hypothalamic nuclei (Figs. 4C, D, dashed lines). These results indicate
that although Arx and Ebf3 are expressed in adjacent territories, they
do not share any common expression area. A similar observation was
made for Lmo3 and Arx expression domains. During forebrain
development, Lmo3 appeared strongly expressed in differentiating
pallidal structures, a domain where Arx was found down-regulated
(Figs. 4E, F, dashed lines). Hence, it is conceivable that both factors
may functionally interact with each other to deﬁne their own spatial
expression.
Forced expression of Ebf3, but not Lmo3, affects tangential migration in
MGE
In Arx mutant basal ganglia, a pronounced impairment of the
cortical oriented tangential migration of GABAergic neurons and
subsequent reduction in the number of GABAergic cortical interneur-
ons were reported (Kitamura et al., 2002; Colombo et al., 2007).
Therefore, we wondered whether the misexpression of Ebf3 or Lmo3
in the subpallium might contribute, at least partially, to such
alterations. To investigate this issue, we misexpressed each gene in
the developingwild-typeMGE by focal electroporation andmonitored
any change in efﬁciency and dynamics of tangential cellularmigration.
Thus, E14.5 wild-type brain slices were maintained in vitro as organ
cultures and expression vectors encoding for GFP, Ebf3 IRES-GFP or
Lmo3 IRES-GFP were delivered by gene electroporation in the MGE.
Cell migration originating from this area was analyzed by following
GFP+ cells for up to 4 DIV (days of in vitro culture). In order to
minimize the variability induced by electroporation efﬁciency and
culture conditions, GFP and Ebf3 IRES-GFP expression vectors were
electroporated on the contralateral MGEs of the same brain slice (Fig.
5A). Only the brain slices in which the electroporation efﬁciencies on
the two contralateral MGEs were found comparable were maintained
in culture (Fig. 5B). In control experiments, GFP+ cells exited the MGE
electroporated site as early as 24 h following DNA delivering, and
streams of cells migrating toward the cortex were visible after 2 days
(Fig. 5C). By day 4, numerous GFP+ cells reached and subsequently
spread throughout the cortical ﬁeld (Figs. 5D, D′). An extremely
different situationwas observed when Ebf3 was ectopically expressed
in the MGE with only a minority of Ebf3-expressing cells able to leave
the MGE and sustain an active migration process toward the cortex,
even after a prolonged time in culture (Figs. 5C, D, D″). A similarreduction in cell dispersion was noticed when Ebf3 was ectopically
expressed in the CGE, another source of robust cell migration (data not
shown). Counting analysis of cells able to cross the cortico-striatal
margin and spread into the cortex was performed on electroporated
brain slices (n=10) belonging to 12 different embryos and it
demonstrated a 5 fold reduction between GFP+ and Ebf3+ migrating
cells (220±18 and 38±10, respectively; Pb0.001, t test) (Fig. 5E).
These ﬁndings provided compelling evidence that Ebf3 ectopic
expression in the ventral telencephalon severely interferes with the
migration of GABAergic neuronal precursors.
A similar approach was used to determine whether Lmo3 ectopic
expression in theMGE could also result in an impairment of tangential
migration. A Lmo3 IRES-GFP expression plasmid was therefore focally
delivered either within the MGE or CGE regions andmigration activity
of electroporated cells was monitored for up to 7 days. Similar to the
control situation (GFP expression only), Lmo3-expressing GFP+ cells
were found to exit from the targeted site and successfully migrate
toward the dorsal cortex (Figs. S2A–B‴). Quantitative analysis
Fig. 5. Ebf3 ectopic expression in wild-type MGE affects interneuron tangential migration toward the cerebral cortex. (A) Experimental assay used to test the effect of the ectopic
expression of Ebf3 inwtMGE neurons: control plasmid GFP (left hemisphere) and Ebf3 IRES-GFP (right hemisphere) constructs were focally injected and electroporated into the two
contralateral MGEs of E14.5 brain slices; the migration pattern of the electroporated neurons was followed for up to 4 DIV (days of in vitro culture). (B–D) Representative examples of
GFP and Ebf3 IRES-GFP electroporated brain slices displaying GFP expression at 1 DIV following electroporation. After 1 DIV, the ﬁrst neurons migrating out of the injection areas are
observed in the control plasmid-electroporated side (left), but not in the Ebf3-overexpressing one (right) (B). By 2 DIV, GFP+ neurons crossed the cortico-striatal boundary; streams
of migrating neurons reaching the cerebral cortex are detected (C). At 4 DIV, an increased number of GFP+ neurons is outlined in the cerebral cortex as compared to Ebf3-
misexpressing side (D–D″). GFP+ neurons that exited the cortico-striatal boundary in both GFP and Ebf3 electroporated MGEs were counted in 10 selected brain slices (respectively,
220±18 and 38±10, ⁎Pb0.001, t test) (E).
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misexpression of either GFP or Lmo3 (216±17 and 198±28,
respectively), suggest that the misexpression of Lmo3 did not alter
cell motility at least in the context of the ventral telencephalon (Fig.
S2C). Thus, in contrast to Lmo3, themisexpression of Ebf3 signiﬁcantly
impairs cell migration in the MGE and CGE and nicely illustrates the
functional differences between two genes similarly up-regulated in
Arx mutants.
Ectopic Arx activity represses Ebf3 expression in vivo
The dramatic effect exerted by Ebf3 ectopic expression on the
migration ability of GABAergic progenitors in the MGE prompted us to
further investigate the functional relationship between Arx and Ebf3.
In particular, we asked whether Arx controls Ebf3 gene expression in
vivo. In fact, it had been reported that Arx acts as a strong
transcriptional repressor, at least in in vitro assays (Collombat et al.,
2005; McKenzie et al., 2007). Therefore, we postulated that Arx might
directly control Ebf3 repression in the ventral telencephalon. To
ascertain this hypothesis, we forced the expression of Arx in themesencephalic tectum, where Ebf3 had previously been found highly
expressed throughout mid-embryogenesis (Garel et al., 1997). Hence,
organotypic slice cultures of mesencephalon were electroporated in
the dorsal side with IRES-GFP or Arx-IRES-GFP expressing plasmids
and Ebf3 activity was analyzed 24 h later. Due to the lack of a
functional Ebf3 antibody, it was assayed by ﬂuorescent in situ
hybridization, which allowed a single cell resolution analysis without
loss of speciﬁcity or signal intensity (Figs. 6A, B). Following
electroporations targeting the mesencephalic dorsal tectum, which
did not alter the morphological structure of the targeted areas (Figs.
6C, D), we observed a different pattern for Ebf3 expression depending
on whether GFP or Arx had been ectopically expressed. In fact, while
cells expressing only GFP were often found co-localized with Ebf3 in
the targeted areas (33.33±3.79 yellow cells/50 electroporated cells)
(Figs. 6E, E′, arrowheads), numerous cells were found negative for
Ebf3 upon Arx misexpression (4.33±1.53 yellow cells/50 electro-
porated cells; Pb0.003, t test), suggesting that Arx and Ebf3 may
mutually exclude each other (Figs. 6F, F′, arrows). To conﬁrm this
hypothesis, the putative repressive activity of Arx on Ebf3 expression
was assayed using an independent experimental setting: the
Fig. 6. Arx ectopic expression is sufﬁcient to repress Ebf3 expression in the mesencephalon. Colorimetric (A) and ﬂuorescent (B) RNA in situ hybridizations performed on E14.5 wild-
type mesencephalic sections indicate that Ebf3 is strongly expressed in the dorsal region (tectum, Te) and in the mesencephalic tegmentum (Tg). Electroporation of one side of the
dorsal mesencephalon (C, D) was used to overexpress control construct GFP (E) or Arx IRES-GFP (F). (E′, F′) High-magniﬁcation views of the electroporated areas revealed a co-
labelling of GFP protein and Ebf3 mRNA in the cells electroporated with the control construct (33.33±3.79 yellow cells/50 electroporated cells; E′, arrowheads), while very little
colocalization could be detected in areas electroporated with the Arx IRES-GFP construct (4.33±1.53 yellow cells/50 electroporated cells; ⁎Pb0.003, t test; F′, arrows). RNA was
extracted from targeted tissues in the dorsal midbrain and processed for quantitative RT-PCRs and the relative expression level determination of Ebf3 in Arx IRES-GFP electroporated
tissues compared to the GFP ones: a 40% reduction in Ebf3 expression was detected (0.6±0.08, Pb0.05; t test).
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IRES-GFP (n=3) were independently isolated and processed for
mRNA isolation and analysis by qPCRs. Interestingly, we found that,
upon forced Arx expression, endogenous Ebf3 transcript contents
were reduced by roughly 40% as compared to GFPmisexpression (Ebf3
relative expression in Arx electroporated tissue compared to control is
0.6±0.08, Pb0.05; t test) (Fig. 6G). These data clearly indicated that
Arx ectopic activity in the mesencephalic tissue is sufﬁcient to
efﬁciently inhibit Ebf3 expression, suggesting that Arx acts as a direct
or indirect repressor of Ebf3.
Ebf3 downregulation in MGE partially rescues migration capability in
Arx mutants
As misexpression of Ebf3 in the MGE led to a severe reduction of
migration activity, we reasoned that its up-regulation in Arx mutant
tissuesmight, at least partly, inhibit interneuronmigration. To test this
hypothesis, we attempted to down-regulate Ebf3 by focally electro-
porating an Ebf3 speciﬁc short-hairpin RNA (shRNA) in the Arx
mutant MGE. 5 shRNAs were thereby tested for their ability to
efﬁciently silence Ebf3 by co-transfecting each of these with an Ebf3-
GFP fused construct in 293T cells. Scrambled shRNA was used as
control. The decrease in GFP expression was used to monitor the
activity of each shRNA in mediating RNA silencing. Among the
different shRNAs tested, only the NM_010096.1-712s1c1 clone was
found to highly down-regulate GFP expression (Fig. S2C). To quantify
its effect, co-transfected cells were harvested and GFP protein levels
were assessed by western-blot (Fig. S2D). Furthermore, the selected
Ebf3 shRNA was additionally validated in vivo by focal injection and
electroporation in dorsal midbrain organotypic slices (Fig. S2E). 48 h
following electroporation, GFP+ areas were dissected and processed
for RNA extraction. Quantitative RT-PCR for Ebf3 revealed that, with
the selected Ebf3 shRNA induced, a 60% reduction in Ebf3 endogenous
transcript levels was achieved (Ebf3 relative expression level was
0.38±0.08, Pb0.001, t test, in Ebf3 shRNA electroporated samples
compared to control).
We then determined the consequences of Ebf3 down-regulation
on cell migration in the Arx mutant MGE. Thus, the selected Ebf3
shRNA expressing plasmid was mixed with pCAGGS-GFP (3:1), focally
electroporated into the MGE of Arx mutant E14.5 brain slices and the
migration of GFP+ cells monitored for 4 DIV. During this period, some
electroporated cells were found to exit the targeted domain andspread following both a radial migration toward the basal ganglia
mantle zone and a tangential route toward the cortex (n= = 5, at
least 3 slices each) (Figs. 7C–C″). However, very few cells were able to
move through the cortico-striatal boundary and reach the lateral
cortex, suggesting that long distance migration capability was not
rescued by this mean (Fig. 7C″). In contrast, the misexpression of GFP
alone or together with a control scrambled shRNA in the mutant MGE
failed to trigger any notable migration at least in this time window, as
reported in previous studies (Figs. 7B–B″ and data not shown)
(Colombo et al., 2007; Kitamura et al., 2002). To ensure that this effect
was solely mediated through Ebf3 silencing, we sought to electro-
porate an Ebf3 cDNA resistant to shRNA-mediated silencing
(Ebf3⁎IRES-GFP); this construct was obtained by mutagenizing 4
nucleotides in the core-sequence recognized by the shRNA, without
altering the amino acid composition in the Ebf3 protein (see Materials
and methods). We, then, co-expressed the Ebf3 shRNA together with
the Ebf3⁎IRES-GFP in ArxmutantMGE and, as expected, cell migration
activity was not detected in 5 brain slices belonging to three
independent set of experiments (Figs. 7D–D″). Thus, our analyses
suggest that the ectopic expression of Ebf3 observed in the Arxmutant
MGE may negatively affect interneuron cellular migration.
Discussion
Identiﬁcation of Arx downstream effectors during ventral telencephalon
development
This study provides a transcriptome dataset of 35 genes whose
expression is modiﬁed in Arx mutant mice. Such a small number of
Arx-regulated genes is surprising, but may be explained by the rather
high thresholds applied on hybridization signals and differential
expression comparisons. Nonetheless, one could expect that the
number of Arx-regulated genes may not be dramatically different
from the present report. One explanation could lie in genetic
redundancy. Arx could interact/transactivate numerous target genes,
but its deﬁciency may not alter the expression of all of these. In fact,
several homeodomain-containing transcription factors are expressed
in the developing ventral telencephalon, including Dlx-1,-2, -5, -6,
Lhx6, Nkx2.1 and Vax1, and may redundantly regulate similar
processes as those controlled by Arx, such as cell migration and cell
fate commitment. For instance, it was previously demonstrated that
Dlx1 and 2 and Arx share a common number of downstream targets
Fig. 7. Ebf3 silencing in Arx mutant MGE marginally rescues short-distance cell migration in the ventral forebrain. Focal electroporations were performed with either a mixture of
control shRNA and GFP-expressing plasmids (3:1 ratio) in wild-type (A–A″) and Arx mutant (B–B″) MGE, or a mixture of Ebf3 shRNA and GFP-expressing plasmids (3:1 ratio) in Arx
mutant (C–C″), MGE of E14.5 forebrain slices. The migration pattern of the electroporated neurons was monitored for up to 4 days in organotypic in vitro culture setting. (A–A″)
Control shRNA electroporation inwild-typeMGE does not inﬂuence the normal interneuron tangential migration, as numerous cells reach the cerebral cortex after 4 DIV (A″). (B–B″)
Arx mutant MGE cells electroporated with control shRNA do exit the injection area, even after 4 DIV. (C–C″) Ebf3 shRNA electroporation in Arx mutant MGE partially rescues cells
migration out of the electroporation site, such cell reaching the neighboring regions although only few could be detected in the lateral cortex. (D–D″) Electroporation of Ebf3 shRNA
in association with Ebf3⁎IRES-GFP (not responding to the Ebf3 shRNA) reintroduced the migration blockage normally observed in Arx mutant MGE.
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suspect that mice deﬁcient for several of these factors may exhibit
more severe phenotypes as compared to single gene inactivation.
Our successive analysis by qPCR and in situ RNA hybridization
conﬁrmed microarray data and strengthened the notion that such
genes may represent Arx effectors. We classiﬁed them into two
different classes depending on the type of alteration in their
expression. Class I genes, such as Ebf3, Magel2, Rasgef1b, Lmo1, 3 and
4, are ectopically expressed in Arx mutant ganglionic eminences
where these are normally not or only marginally detected. These
ﬁndings strongly support the notion that Arx may act as regional key
selector factor to promote the correct identity of the ganglionic
eminences through transcriptional repression of speciﬁc genes. In
particular, some of these genes like Lmo1, 3 and 4were found stronglyderepressed in the MGE, but not in the LGE, although Arx is normally
equally expressed in both areas. These results indicate that Arx-
dependent transcriptional repression is more stringent in the MGE
territory and suggest that other LGE-speciﬁc factors may be
responsible for the silencing of these genes. Conversely, Class II
regroups those genes down-regulated in their normal expression
domain upon Arx deﬁciency. This is consistent with the idea that such
genes represent secondary targets or that Arx may also act as
transcriptional activator, as suggested in previous biochemical studies
(McKenzie et al., 2007). Among class II genes, Bmper (also known as
Crossveinless-2, CV2) exhibits speciﬁc features worth to be high-
lighted. In fact, Bmper is the only gene tested by in situ RNA
hybridization displaying a reduction in gene expression not only in
the ganglionic eminences, but also in the dorsal cerebral cortex. In wt,
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ventricular proliferating cortical layer where Arx is also transcribed
(Cobos et al., 2005a,b). Thus, these ﬁndings suggest that Bmper may
act as an Arx co-regulated gene during telencephalon development
and that both genes may belong to the same “synexpression group”
(Niehrs and Pollet, 1999). Bmper encodes a secreted protein binding to
BMP factors that, depending on its concentration and biological
context, can exert a robust pro- or anti-BMP activity (Cofﬁnier et al.,
2002; Rentzsch et al., 2006; Ambrosio et al., 2008; Kelley et al., 2009).
Due to the pleiotropic functions exerted by the BMP signaling in
telencephalon development, Arx-dependent abnormalities may ori-
ginate, at least in part, in an early misregulation of BMP local
concentrations (Hébert et al., 2002; Fernandes et al., 2007).
Arx-mediated repression of Ebf3 is required for tangential migration
Among the genes misexpressed in Arxmutant MGE, Ebf3 displayed
the highest increase in expression, suggesting a strong interaction
between this factor and Arx in the MGE. Interestingly, Fulp et al.
(2008) have recently found that Arx binds to the Ebf3 minimal
promoter and is able to repress its transcription in vitro. In the light of
the results presented in this report, it appears that Arx functions as an
Ebf3 direct transcriptional inhibitor and contributes to the restriction
of Ebf3 expression to the hypothalamus and midbrain. In addition, we
provide evidence that Ebf3 activation in the MGE inhibits tangential
cell migration, while its silencing in Arx mutant MGE partially rescues
this alteration. These observations raise the question about the
mechanisms underlying Ebf3 function in regulating MGE tangential
migration. Ebf3 is normally expressed in the developing hindbrain and
spinal cord where it promotes neuronal differentiation and neuronal
radial migration (Garcia-Dominguez et al., 2003). However, no sign of
premature differentiation in Arx mutant MGE has hitherto been
reported. Further, Ebf3 ectopic expression in wt MGE did not elicit
precocious neuronal differentiation as assessed by β-III-tubulin and
Map2 stainings (unpublished results). Thus, it appears that Ebf3
ectopic expression in a heterologous tissue mediates different effects
as expected from its function in its endogenous context. Interestingly,
although we observed a dramatic arrest in tangential oriented
migration, neuronal movements on the radial axis were sufﬁciently
maintained. This ﬁnding may suggest that Ebf3 activity is permissive
to radial migration, as found mainly in tissues with Ebf3 endogenous
expression, but precludes other types of cell movements. However,
Ebf3 ectopic up-regulation should be considered only as a partial
molecular cause of the Arx-dependent cellular migration defects. In
fact, its downregulation elicited only a mild rescue of migration in Arx
mutant MGE.
New candidate genes for mediating Arx activity in controlling neuronal
migration
Of particular interest, among the different genes found to be down-
regulated in Arx mutant tissues, were Cxcr4 and its cognate receptor
Cxcr7 (also known as Rdc1 or Cmkor1). Indeed, recent studies have
shown that signaling by the chemokine receptor Cxcr4 and its ligand
Cxcl12 (also known as stromal cell-derived factor-1 (SDF-1)) are
critical for correct neuronal migration. In fact, mice carryingmutations
in either gene display defects in the positioning of neocortical
interneurons during migration, both in the superﬁcial and deep
migratory streams. In addition, Cxcl12 expression in meninges
presumably promotes the localization of interneurons in the marginal
zone (MZ) (Stumm et al., 2003, 2007). Additional studies indicated
that meningeal expression of Cxcl12 is crucial for organizing the
marginal zone positioning and migration of Cajal–Retzius cells and
GABAergic interneurons (Borrell and Marín, 2006; Li et al., 2008;
López-Bendito et al., 2008). Altogether, these data suggest that Arx
may promote cellularmigration by activating at least one of the crucialreceptor for the chemokine signaling. However, Arx mutant inter-
neurons display an aberrant dynamics of cellular migration, which is
only partially overlapping with that described for Cxcr4 mutant
neurons (Colasante G. and Broccoli V., unpublished results). Interest-
ingly, we also observed a down-regulation of Cxcr7 and conﬁrmed it
by qPCRs. Cxcr7 has not yet been studied in this biological context,
however it has been reported that its expression is detectable in
developing cortical interneurons (Zhao et al., 2008). Interestingly,
Cxcr7 has been found regulating the migration of lateral line cells in
zebraﬁsh (Dambly-Chaudiere et al., 2007; Valentin et al., 2007),
suggesting a more general role of Cxcr7 in controlling cell migration.
Future studies will be necessary to evaluate how the downregulation
of both Cxcr4 and 7 might impinge on the aberrant migration activity
of the Arx mutant GABAergic interneurons.
Another gene whose misexpression in the ventral telencephalon
can induce cell movement defects is Rasgef1b. Rasgef1b is coding for a
Ras activating factor and its function may be related to cell migration,
neurite extension or cytoskeleton remodelling. It is worth noticing
that Rasgef1b expression is normally restricted to the striatal
differentiated mantle zone while, in the Arx mutant telencephalon,
its expression is expanded into the SVZ regions of MGE and LGE. Thus,
a working hypothesis would be that Rasgef1b ectopic expression
might be incompatible with those processes involved in cellular
migration.
In conclusion, we identiﬁed a group of Arx-regulated genes using
global gene expression proﬁling. Among these, a number was found
strongly up-regulated and ectopically expressed in the MGE, suggest-
ing a role for Arx as a selector gene preserving correct MGE identity.
Interestingly, some of those had previously been implicated in
controlling interneuron tangential migration, while others have not
been investigated in this context. Among the latter was Ebf3.
Importantly, its misexpression was found sufﬁcient to block neuronal
tangential movements while its silencing in Arxmutant tissue rescued
only partially tangential migration defects.
Thus, the identiﬁcation of the aberrant molecular network
responsible of the altered cell migration observed in Arx-mutant
forebrains, will be crucial for devising genetic or cellular therapeutic
strategies to correct or ameliorate this severe pathological phenotype.
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